Table 2:
showing various hereditary, sporadic and epigenetic associations with PCa incidence primarily sourced from Shen et al.,126 and other sources19, 127 can be consulted.
| Hereditary | Sporadic | Epigenetic |
|---|---|---|
| ELAC | TLR4 | NKX3.1 |
| RNASEL | CDKN1B | Myc |
| MSRI | AR | TMPRSS2-ERG |
| NBSI | CYP17 | PTEN |
| CHEK2 | SRD5A2 | Ezhz |
| HOXB13 | Vitamin D receptor | miRNAs |
| HPC1 | CDKN1A | Signalling pathways-Akt/mTOR & MAPK |
| 8q24 & 17q | CDKN1B | Oncogene tyrosin kinase |
| HNF1B | EGFR | Developmental Signalling |
| 17q21 | CAV1 | RASSF1 |
| PCA3 | MSR | |
| 12q24 | NKX3.1 | |
| 2p16 | c-myc | |
| 10911 | PTEN | |
| SPARCL1 on 4q22.1 | RbE-CAD | |
| PTPRR on 12q15 | AR | |
| 10p14 | ANX7LZTSI | |
| Fox P1 | ||
| KAI1 | ||
| GSTP1 | ||
| APC | ||
| ETS P53 |